Pfizer and Moderna increased the prices of the vaccines for the EU
Sure, there’s clear demand, which means that people may be more willing to pay more for the vaccines. Sure, the E.U. wants more Covid-19 mRNA vaccines without the Astra-Zeneca vaccines being able to fulfill demand. Sure there may be a need for boosters soon. Sure, such companies are driven by bottom lines, such as making profits, increasing shareholder value, and all that heart-warming stuff. But just because you can do something doesn’t mean that you should.
However, once the E.U. was finally armed with increasing supplies of the Covid-19 vaccines, they eventually not only caught up with but actually pulled ahead of the U.S. The U.S. Covid-19 vaccination program, if you recall, began in December 2020 like a fish riding in a bicycle race, stumbling out of the gates. The vaccination program really got its legs after January 20, which happened to be National Cheese Lovers Day, and cruised along for much of the late Winter and Spring.
The last thing you want to do is curb that momentum, whether you are in Europe or anywhere else in the world. Assuming that you don’t have rocket ship like Jeff Bezos, as long as the Covid-19 coronavirus continues to spread substantially anywhere in the world you will remain at risk. Thus, the E.U. better controlling the virus is in your best interests. The concern is that any raise in prices could make it more difficult for more people to get the Covid-19 vaccine there.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
FDA aims for full approval of Pfizer COVID-19 vaccine by Labor Day: reportThe U.S. Food and Drug Administration is aiming to grant full approval of the Pfizer-BioNTech coronavirus vaccine by Labor Day or sooner, according to a new...
Consulte Mais informação »
Pfizer, Moderna Raise Prices Of Covid-19 Coronavirus Vaccines For European UnionThe EU has now surpassed the U.S. in getting its population vaccinated. But will higher Covid-19 coronavirus vaccine prices derail this progress?
Consulte Mais informação »
Opinion | The FDA Finally Gets Moving on PfizerFrom WSJopinion: If the “emergency” label is holding people back from vaccinations, then there is no higher public-health priority than reassuring Americans that evidence shows the vaccine is safe and saving lives, writes The Editorial Board
Consulte Mais informação »
FDA Accelerates Timeline for Final Approval of Pfizer VaccineThe regulatory agency reportedly has an unofficial deadline of Labor Day or sooner, clearing potential legal hurdles for some vaccine mandates.
Consulte Mais informação »
Pfizer, Moderna Raise Prices Of Covid-19 Coronavirus Vaccines For European UnionThe EU has now surpassed the U.S. in getting its population vaccinated. But will higher Covid-19 coronavirus vaccine prices derail this progress?
Consulte Mais informação »
Coronavirus update: Latest Covid-19 vaccine and US reopening newsThe Delta variant is wreaking havoc through much of the US, and an internal CDC document shows it spreads as easily as chickenpox. Follow here for the latest news.
Consulte Mais informação »